An International Clinical Program for the Diagnosis and Treatment of Children With Ependymoma

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(40 sites)

Austria

Medical University of Graz-Department of Pediatrics and Adolescent Medicine, Graz

Belgium

CHR de la CITADELLE, Liège

Czechia

University Hospital Brno, Brno

Denmark

Aarhus University Hospital, Aarhus

France

CHRU STRASBOURG - Hôpital de Hautepierre, Strasbourg, Bas-Rhin

AP-HM - Hôpital d'Enfants de La Timone, Marseille, Bouches-du-Rhône

CHU Dijon - Hôpital des Enfants, Dijon, Côte d'Or

CHRU BESANCON - Hôpital Jean Minjoz, Besançon, Doubs

CHRU BREST - Hôpital Morvan, Brest, Finistère

CHU de Bordeaux-Hôpital des enfants Pellegrin, Bordeaux, Gironde

CHU de TOULOUSE - Hôpital des Enfants, Toulouse, Haute-Garonne

CHRU MONTPELLIER - Hôpital Arnaud de Villeneuve, Montpellier, Herault

CHU de RENNES - Hôpital Sud, Rennes, Ille-et-Vilaine

CHRU Tours - Hôpital Clocheville, Tours, Indre-et-Loire

CHU GRENOBLE - Hôpital Couple-Enfant, La Tronche, Isère

Chu Angers, Angers, Maine-et-Loire

CHU REIMS - American Memorial Hospital, Reims, Marne

Germany

University Medical Center Hamburg-Eppendorf, Hamburg

Ireland

Our Lady's Children's Hospital, Dublin

Italy

Fondazione IRCCS Istituto Nazionale dei Tumori, Milan

Netherlands

Princess Maxima Center for pediatric oncology, Utrecht

Norway

Department of Paediatric, Haukeland University Hospital, Bergen

Slovenia

University Medical Center Ljubljana, Ljubljana

Spain

Hospitales Universitarios Virgen Macarena y Virgen del Rocío Avda, Seville

Sweden

Skåne University Hospital, Lund

Switzerland

University Children's Hospital, Zurich

United Kingdom

Queen's Medical Centre, Nottingham